| Name | Title | Contact Details |
|---|
Meridian Health Plan is the largest Medicaid HMO in the State of Michigan, providing health care to over 290,000 Medicaid enrollees through a contract with the Michigan Department of Community Health (MDCH). MHP is a physician-owned, physician-managed Medicaid health plan. Its corporate headquarters are located in Detroit, Michigan. Currently, MHP operates in 67 counties. Meridian Health Plan's Michigan Medicaid HMO received an Excellent Accreditation rating from the National Committee for Quality Assurance (NCQA). Excellent is the highest possible Accreditation status from NCQA. To continuously improve the quality of care in a low resource environment
Alcohol Research Group is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Floyd Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Floyd Medical Center is based in Rome, GA. You can find more information on Floyd Medical Center at www.floydmed.org
Apply for and manage the VA benefits and services you’ve earned as a Veteran, Servicemember, or family member—like health care, disability, education, and more.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.